NCT01579006View on ClinicalTrials.gov

Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

184

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Tocilizumab

Trial Locations (14)

18101

Afula

31048

Haifa

34362

Haifa

38100

Hadera

44281

Kfar Saba

52621

Ramat Gan

91240

Jerusalem

3109601

Haifa

4937211

Petah Tikva

4941492

Petah Tikva

5262000

Ramat Gan

6093000

Beer Yaakov

8410101

Beersheba

9112001

Jerusalem

Sponsors

Collaborators (1)

Clalit Health Services
All Listed Sponsors
collaborator

Clalit Health Services

OTHER

lead

Hoffmann-La Roche

INDUSTRY

NCT01579006 - Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter